EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Neuroblastoma—A Review of Combination Immunotherapy

Barbara Pieniążek iD, Katarzyna Cencelewicz iD, Patrycja Bździuch iD, Łukasz Młynarczyk iD, Monika Lejman iD, Joanna Zawitkowska iD, Katarzyna Derwich iD

International Journal of Molecular Sciences · 15.07.2024 · 25 (14) · 7730

DOI: 10.3390/ijms25147730 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.07.2024. Verfasst von Barbara Pieniążek und 6 weiteren Autor:innen. Beteiligte Einrichtung: Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland. Hauptthemen laut MEDLINE: Neuroblastoma, Immunotherapy. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 126 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neuroblastoma is the most common extracranial solid tumor found in childhood and is responsible for 15% of deaths among children with cancer. Although multimodal therapies focused on surgery, chemotherapy, radiotherapy, and stem cell transplants have favorable results in many cases, the use of conventional therapies has probably reached the limit their possibility. Almost half of the patients with neuroblastoma belong to the high-risk group. Patients in this group require a combination of several therapeutic approaches. It has been shown that various immunotherapies combined with conventional methods can work synergistically. Due to the development of such therapeutic methods, we present combinations and forms of combining immunotherapy, focusing on their mechanisms and benefits but also their limitations and potential side effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeuroblastomaImmunotherapyHumansCombined Modality TherapyAnimals

Stichwörter der Autor:innen

cancercombining therapyimmunotherapyneuroblastomapediatric oncology

Autor:innen und Institutionen

  • Student Scientific Society of Department of Pediatric Hematology, Oncology and Transplantology, Medical University of Lublin, 20-093 Lublin, Poland.
  • Department of Pediatric Oncology, Hematology and Transplantology, Poznan University of Medical Sciences, 60-572 Poznań, Poland.
  • Independent Laboratory of Genetic Diagnostics, Medical University of Lublin, 20-093 Lublin, Poland.
  • Department of Pediatric Hematology, Oncology and Transplantation, Medical University of Lublin, 20-093 Lublin, Poland.

ORCID-Profile: Barbara Pieniążek, Katarzyna Cencelewicz, Patrycja Bździuch, Łukasz Młynarczyk, Monika Lejman, Joanna Zawitkowska, Katarzyna Derwich

Zitieren

APA

Pieniążek, B., Cencelewicz, K., Bździuch, P., Młynarczyk, Ł., Lejman, M., Zawitkowska, J., & Derwich, K. (2024). Neuroblastoma—A Review of Combination Immunotherapy. International Journal of Molecular Sciences, 25(14), 7730. https://doi.org/10.3390/ijms25147730

Vancouver

Pieniążek B, Cencelewicz K, Bździuch P, Młynarczyk Ł, Lejman M, Zawitkowska J, et al. Neuroblastoma—A Review of Combination Immunotherapy. International Journal of Molecular Sciences. 2024;25(14):7730. doi:10.3390/ijms25147730

BibTeX
@article{Pieniek2024,
  author = {Pieniążek, Barbara and Cencelewicz, Katarzyna and Bździuch, Patrycja and Młynarczyk, Łukasz and Lejman, Monika and Zawitkowska, Joanna and Derwich, Katarzyna},
  title = {Neuroblastoma—A Review of Combination Immunotherapy},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {14},
  pages = {7730},
  doi = {10.3390/ijms25147730}
}
Kostenlos starten →